CVS
CVS Health Corp
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
USD 89.79
Buy <=wait / entry
USD 77.00
Trim >=take some off
USD 95.00
Thesis breakA formal guidance cut to 2026 adjusted EPS, a sustained Aetna medical benefit ra...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 33% | 100 / 100 | 33.0 |
| Base case | 48% | 62 / 100 | 29.8 |
| Bear case | 19% | 10 / 100 | 1.9 |
| Weighted conviction | 65 / 100 - BUY | ||
Top risks
- Raised full-year 2026 EPS and cash flow guidance following strong Q2 2026 results with adjusted EPS up 40%
- Declaration of quarterly dividend of $0.665 per share payable November 2026
- Strong Buy analyst consensus from 19 ratings with median target price of $113-$116